KEPING XIE to Nitric Oxide Synthase Type II
This is a "connection" page, showing publications KEPING XIE has written about Nitric Oxide Synthase Type II.
Connection Strength
0.640
-
Tumors face NO problems? Cancer Res. 2006 Jul 01; 66(13):6459-62.
Score: 0.065
-
Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors. Proc Natl Acad Sci U S A. 2005 Jun 14; 102(24):8758-63.
Score: 0.061
-
Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase. Cancer Res. 2003 Jul 15; 63(14):3855-9.
Score: 0.053
-
Contribution of nitric oxide-mediated apoptosis to cancer metastasis inefficiency. Free Radic Biol Med. 2003 Apr 15; 34(8):969-86.
Score: 0.052
-
A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis. Oncogene. 2003 Mar 27; 22(12):1771-82.
Score: 0.052
-
Genetic disruption of host interferon-gamma drastically enhances the metastasis of pancreatic adenocarcinoma through impaired expression of inducible nitric oxide synthase. Oncogene. 2001 Oct 18; 20(47):6930-7.
Score: 0.047
-
Regulation of interleukin-8 expression by nitric oxide in human pancreatic adenocarcinoma. J Interferon Cytokine Res. 2001 Jul; 21(7):529-37.
Score: 0.046
-
Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion. Int J Cancer. 2001 Mar 01; 91(5):607-11.
Score: 0.045
-
Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. Cancer Res. 2001 Jan 01; 61(1):71-5.
Score: 0.045
-
A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy. Int J Pancreatol. 2001; 29(1):37-46.
Score: 0.045
-
Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53. Cancer Res. 1999 May 01; 59(9):2072-5.
Score: 0.040
-
Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev. 1998 Mar; 17(1):55-75.
Score: 0.037
-
Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide. Clin Cancer Res. 1997 Dec; 3(12 Pt 1):2283-94.
Score: 0.036
-
Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum Gene Ther. 1998 Apr 10; 9(6):845-54.
Score: 0.009
-
Use of retroviral vectors encoding murine inducible nitric oxide synthase gene to suppress tumorigenicity and cancer metastasis of murine melanoma. Cancer Biother Radiopharm. 1997 Jun; 12(3):167-75.
Score: 0.009